Dear Colleagues,


This is the final announcement for 2020 Symposium organized by Asian 
Pharmacometrics Network (APN), to be held virtually on November 18-19.



The APN (http://www.go-apn.org/) was created to enhance regional development 
and networking opportunities in pharmacometrics and to provide training 
opportunities to future pharmacometricians across Asia. Currently the APN has 
14 member countries.



At the APN meeting this year, speakers invited from more than10 Asian countries 
will present on various topics, which will make the APN meeting a unique 
pan-Asian forum in the region. In particular, students will be invited to 
podium presentations to encourage the participation of future 
pharmacometricians.



As a post-symposium event, on November 20, there will be a pharmacometrics 
workshop for Julia Hub, organized by PUMAS-AI.



For both symposium and workshop, registration is free and its procedure and the 
program are found at https://www.sophas.net/apn2020.php. For more information, 
contact the local host Dr. Surulivelrajan Mallayasamy of Manipal Academy of 
Higher Education of India at 
msvragavra...@gmail.com<mailto:msvragavra...@gmail.com>



Best regards,



APN Chair

Kyungsoo Park

---------------------------------------
Kyungsoo Park, PhD, MD
Professor of Pharmacology
Yonsei University College of Medicine
50-1 Yonsei-Ro, Seoul 03722, Korea
Tel +82-2-2228-1735 / Fax +82-2-313-1894

상기 메일은 지정된 수신인 만을 위한 것이며 부정경쟁 방지 및 영업비밀보호에 관한 법률을 포함하여 관련 법령에 따라 보호의 대상이 되는 
영업비밀, 산업기술 등을 포함하고 있을 수 있습니다. 본 문서에 포함된 정보의 전부 또는 일부를 무단으로 제3자에게 공개, 배포, 복사 또는 
사용하는 것은 엄격히 금지됩니다. 본 메일이 잘못 전송된 경우, 발신인에게 알려주시고 즉시 삭제하여 주시기 바랍니다. The above 
message is intended solely for the named addressee and may contain trade 
secret, industrial technology or privileged and confidential information 
otherwise protected under applicable law including the Unfair Competition 
Prevention and Trade Secret protection act. Any unauthorized dissemination, 
distribution, copying or use of the information contained in this communication 
is strictly prohibited. If you have received this communication in error, 
please notify the sender by email and delete this communication immediately.

Reply via email to